Neuroendocrinology News

AUSTIN, Texas — Patients with cancer treated with immune checkpoint inhibitors are at risk for developing pituitary, thyroid and glucose metabolism dysfunctions, according to a speaker.

AUSTIN, Texas — Preoperative identification of patients with silent adrenocorticotrophic hormone-secreting tumors could potentially change the approach to management. A new study aimed to determine whether a preoperative adrenocorticotrophic hormone stimulation test for evaluation of nonfunctional pituitary macroadenoma could aid in identifying adrenocorticotrophic hormone-staining pathology yielded large variability and did not allow clinical utility.

Patients with idiopathic hyperprolactinemia have a higher risk for anterior pituitary hormone deficiency that may require hormone therapy compared with patients with microprolactinoma, study data show.

Insulin-like growth factor I values can be effectively normalized with high-frequency and high-dose lanreotide autogel in adults with active acromegaly uncontrolled by long-term conventional somatostatin receptor ligand therapy, according to researchers from Italy.

Men with hypogonadotropic hypogonadism caused by congenital combined pituitary hormone deficiency may see an increase in serum testosterone levels with the use of gonadotropin-releasing hormone therapy, according to findings from researchers in China.

ORLANDO, Fla. — In this video exclusive, Maria Fleseriu, MD, FACE, professor of medicine and neurological surgery at Oregon Health & Science University in Portland, discusses updates in the management of acromegaly.

ORLANDO, Fla. — Specific microbacteria in the human gut are associated with hormones of the hypothalamic–pituitary–adrenal axis, and the associations vary with substance use and type 2 diabetes, according to findings of a cross-sectional study.

Women with multiple endocrine neoplasia type 1 are at greater risk for developing early-onset breast cancer compared with women without the disease, according to findings from a cross-sectional study.

Adults with acromegaly report impaired quality of life compared with adults without the disease, and the impairments remain despite long-term disease control, according to findings published in Clinical Endocrinology.

Previous estrogen exposure in women with multiple endocrine neoplasia type 1 may affect size of pancreatic neuroendocrine tumors, but exposure is not correlated with time to pancreatic neuroendocrine tumor diagnosis, according to published findings.